Angiogenesis and signal transduction in endothelial cells

Cellular and Molecular Life Sciences

Volumn 61, Issue 17, 2004, Pages 2224-2243

  Munoz Chapuli R ^a   Quesada, A R ^a   Medina, M Ángel ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Angiogenesis; Cell migration; Cell proliferation; Cell survival; Endothelium; Signal transduction

Indexed keywords

CADHERIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SPHINGOSINE 1 PHOSPHATE; STAT PROTEIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL ULTRASTRUCTURE; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FOCAL ADHESION; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GTP PHOSPHOHYDROLASES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 4644356480     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4070-7     Document Type: Review

References (254)

1. Hobson B. and Denekamp J. (1984) Endothelial proliferation in tumors and normal tissues: continuous labeling studies. Br. J. Cancer 49: 405-413
2. Guo D., Jia Q., Song H. Y., Warren R. S. and Donner D. B. (1995) Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270: 6729-6733
3. Seo M. S., Kwak N., Ozaki H., Yamada H., Okamoto N., Yamada E. et al. (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol. 154: 1743-1753
4. Faehling M., Kroll J., Fohr K. J., Fellbrich G., Mayr U., Trischler G. et al. (2002) Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J. 16: 1805-1807
5. Bauer K. S., Cude K. J., Dixon S. C., Kruger E. A. and Figg W. D. (2000) Carboxyamido-friazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway. J. Pharmacol. Exp. Ther. 292: 31-37
6. Kanno S., Oda N., Abe M., Terai Y., Ito M., Shitara K. et al. (2000) Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 19: 2138-2146
7. Wu L. W., Mayo L. D., Dunbar J. D., Kessler K. M., Baerwald M.R., Jaffe E. A. et al. (2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275: 5096-5103
8. Hartman G. D., Fraley M. E. and Bilodeau MT. (2002) Kinase insert domain-containing receptor kinase inhibitors as antiangiogenic agents. Expert Opin. Investig. Drugs 11: 737-745
9. Danis R., Criswell M., Orge F., Wancewicz E., Stecker K., Henry S. et al. (2003) Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization. Curr. Eye Res. 26: 45-54
10. Bullard L. E., Qi X. and Penn J. S. (2003) Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis. Invest. Ophthalmol. Vis. Sci. 44: 1722-1731
11. Meadows K. N., Bryant P. and Pumiglia K. (2001) Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J. Biol. Chem. 276: 49289-49298
12. Brakenhielm E., Cao R. and Cao Y. (2001) Suppression of angiogenesis, tumor growth and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15: 1798-1800
13. Morbidelli L., Chang C. H., Douglas J. G., Granger H. J., Ledda F. and Ziche M. (1996) Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270: H411-415
14. Parenti A., Morbidelli L., Cui X. L., Douglas J. G., Hood J. D., Granger H. J. et al. (1998) Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273: 4220-4226
15. He H., Venema V. J., Gu X., Venema R. C., Marrero M. B. and Caldwell R. B. (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J. Biol. Chem. 274: 25130-25135
16. Johns A. and Zolner S. (2000) Nitric oxyde and angiogenesis. In: Angiogenesis in Health and Disease, pp. 191-198, Rubany G.M. (ed.), Marcel Dekker, New York
17. Donnini S. and Ziche M. (2002) Constitutive and inducible nitric oxide synthase: role in angiogenesis. Antioxid. Redox Signal. 4: 817-823
18. Zachary I. and Gliki G. (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49: 568-581
19. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M. and Heldin C. H. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269: 26988-26995
20. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S. and Shibuya M. (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGE. Oncogene 10: 135-147
21. Hiratsuka S., Minowa O., Kuno J., Noda T. and Shibuya M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95: 9349-9354
22. Gille H., Kowalski J., Yu L., Chen H., Pisabarro M. T., Davis-Smyth T. et al. (2000) A repressor sequence in the juxta-membrane domain of Flt-1 (VEGFR1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. EMBO J. 19: 4064-4073
23. Cross M. J., Hodgkin M. N., Roberts S., Landgren E., Wakelam M. J. and Claesson-Welsh L. (2000) Tyrosine 766 in the fibroblast growth factor receptor-1 is required for FGF stimulation of phospholipase C, phospholipase D, phospholipase A, phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cells. J. Cell Sci. 113: 643-651
24. Larsson H., Klint P., Landgren E. and Claesson-Welsh L. (1999) Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274: 25726-25734
25. Klint P., Kanda S., Kloog Y. and Claesson-Welsh L. (1999) Contribution of Src and Ras pathways in FGF2 induced endothelial cell differentiation. Oncogene 18: 3354-3364
26. Eliceiri B. P., Paul R., Schwartzberg P. L., Hood J. D., Leng J. and Cheresh D. A. (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4: 915-924
27. Hanafusa H., Torii S., Yasunaga T. and Nishida E. (2002) Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4: 850-858
28. Cabrita M. A. and Christofori G. (2003) Sprouty proteins: antagonists of endothelial cell signaling and more. Thromb. Haemost. 90: 586-590
29. Matsumoto T., Turesson I., Book M., Gerwins P. and Claesson-Welsh L. (2002) p38 MAP kinase negatively regulates endothelial cell survival, proliferation and differentiation in FGF2-stimulated angiogenesis. J. Cell Biol. 156: 149-160
30. Birchmeier C., Birchmeier W., Gherardi E. and Vande Woude G. F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4: 915-925
31. Sengupta S., Sellers L. A., Li R. C., Gherardi E., Zhao G., Watson N. et al. (2003) Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation 107: 2955-2961
32. Wajih N. and Sane D. C. (2003) Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Blood 101: 1857-1863
33. Ruegg C. and Mariotti A. (2003) Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell. Mol. Life Sci. 60: 1135-1157
34. Eliceiri B. P., Klemke R., Stromblad S. and Cheresh D. A. (1998) Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell. Biol. 140: 1255-1263
35. Hood J. D., Frausto R., Kiosses W. B., Schwartz M. A. and Cheresh D. A. (2003) Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J. Cell Biol. 162: 933-943
36. Senger D. R., Perruzzi C. A., Streit M., Koteliansky V. E., de Fougerolles A. R. and Detmar M. (2002) The alpha(1) beta(1) and alpha(2) beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration and tumor angiogenesis. Am. J. Pathol. 160: 195-204
37. Friedlander M., Brooks P. C., Shaffer R. W., Kincaid C. M., Varner J. A. and Cheresh D. A. (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500-1502
38. Bader B. L., Rayburn H., Crowley D. and Hynes RO (1998) Extensive vasculogenesis, angiogenesis and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95: 507-519
39. Hodivala-Dilke K. M., McHugh K. P., Tsakiris D. A., Rayburn H., Crowley D., Ullman-Cullere M. et al. (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103: 229-238
40. Reynolds L. E., Wyder L., Lively J. C., Taverna D., Robinson S. D., Huang X. et al. (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 8: 27-34
41. Stromblad S., Becker J. C., Yebra M., Brooks P. C. and Cheresh D. A. (1996) Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J. Clin. Invest. 98: 426-433
42. Stromblad S., Fotedar A., Brickner H., Theesfeld C., Aguilar de Diaz E., Friedlander M. et al. (2002) Loss of p53 compensates for alpha v-integrin function in retinal neovascularization. J. Biol. Chem. 277: 13371-13374
43. Zhang Y., Griffith E. C., Sage J., Jacks T. and Liu J. O. (2000) Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc. Natl. Acad. Sci. USA 97: 6427-6432
44. Yeh J. R., Mohan R. and Crews C. M. (2000) The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc. Natl. Acad. Sci. USA 97: 12782-12787
45. Yang J. T., Rayburn H. and Hynes R. O. (1993) Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 19: 1093-1105
46. Francis S. E., Goh K. L., Hodivala-Dilke K., Bader B. L., Stark M., Davidson D. et al. (2002) Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 22: 927-933
47. Zhong J., Eliceiri B., Stupack D., Penta K., Sakamoto G., Quertermous T. et al. (2003) Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J. Clin. Invest. 112: 30-41
48. Masson-Gadais B., Houle F., Laferriere J. and Huot J. (2003) Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGE. Cell Stress Chap. 8: 37-52
49. Smyth S. S. and Patterson C. (2002) Tiny dancers: the integrin-growth factor nexus in angiogenic signaling. J. Cell Biol. 158: 17-21
50. Cheresh D. A. and Stupak D. G. (2002) Integrin-mediated death: an explanation of the integrin-knockout phenotype? Nat. Med. 8: 193-194
51. Leu S. J., Lam S. C. and Lau L. F. (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J. Biol. Chem. 277: 46248-46255
52. Brigstock D. R. (2003) The CCN family: a new stimulus package. J. Endocrinol. 178: 169-175
53. Brigstock D. R. (2002) Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis. 5: 153-165
54. Posey J. A., Khazaeli M. B., DelGrosso A., Saleh M. N., Lin C. Y., Huse W. et al. (2001) A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer. Cancer Biother. Radiopharm. 16: 125-132
55. Shu X., Wu W., Mosteller R. D. and Broek D. (2002) Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 22: 7758-7768
56. Kimura T., Watanabe T., Sato K., Kon J., Tomura H., Tamama K. et al. (2000) Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem. J. 348: 71-76
57. Slevin M., Krupinski J., Kumar S. and Gaffney J. (1998) Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab. Invest. 78: 987-1003
58. Savani R. C., Cao G., Pooler P. M., Zaman A., Zhou Z. and DeLisser H. M. (2001) Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J. Biol. Chem. 276: 36770-36778
59. Kobayashi H., Suzuki M., Kanayama N., Nishida T., Takigawa M. and Terao T. (2002) CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Int. J. Cancer. 102: 379-389
60. Korpelainen E. I., Karkkainen M., Gunji Y., Vikkula M. and Alitalo K. (1999) Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18: 1-8
61. Jones N. and Dumont D. J. (1998) The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 17: 1097-1108
62. Jones N., Chen S. H., Sturk C., Master Z., Tran J., Kerbel R. S. et al. (2003) A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function. Mol. Cell. Biol. 23: 2658-2668
63. Valdembri D., Serini G., Vacca A., Ribatti D. and Bussolino F. (2002) In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J. 16: 225-227
64. Zeng Z. Z., Yellaturu C. R., Neeli I. and Rao G. N. (2002) 5(S)-hydroxyeicosatetraenoic acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and phosphatidylinositol 3-kinase/Akt signaling, leading to induction of expression of basic fibroblast growth factor 2. J. Biol. Chem. 277: 41213-41219
65. Szekeres C. K., Trikha M., Nie D. and Honn K. V. (2000) Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 275: 690-695
66. Szekeres C. K., Tang K., Trikha M. and Honn K. V. (2000) Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells. J. Biol. Chem. 275: 38831-33841
67. Nor J. E. and Polverini P. J. (1999) Role of endothelial cell survival and death signals in angiogenesis. Angiogenesis 3: 101-116
68. Adams J. M. and Cory S. (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26: 61-66
69. Frisch S. M. and Ruoslahti E. (1997) Integrins and anoikis. Curr. Opin. Cell Biol. 9: 701-706
70. Stupack D. G., Puente X. S., Boutsaboualoy S., Storgard C. M. and Cheresh D.A. (2001) Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155: 459-470
71. Gerber H. P., McMurtrey A., Kowalski J., Yan M., Keyt B. A., Dixit V. et al. (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway Requirement for Flk-1/KDRactivation. J. Biol. Chem. 273: 30336-30343
72. López-Farre A., Farre J., Sánchez de Miguel L., Romero J., González-Fernández F. et al. (1998) Disfunción endotelial: una respuesta global. Rev. Esp. Cardiol. 51: 18-22
73. López-Farre A., Sánchez-de-Miguel L., Caramelo C., Gómez-Macías J., García R., Mosquera J. R. et al. (1997) Role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells. Am. J. Physiol. 272: H760-768
74. Morbidelli L., Chang C. H., Douglas J. G., Granger H. J., Ledda Tsukada T., Eguchi K. et al. (1995) Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem. Biophys. Res. Commun. 210: 1076-1082
75. Choi M. E. and Ballermann B. J. (1996) Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. J. Biol. Chem. 270: 21144-21150
76. Tsukada T., Eguchi K., Migita K., Kawabe Y., Kawakami A., Matsuoka N. et al. (1995) Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem. Biophys. Res. Commun. 210: 1076-1082
77. Robaye B., Mosselmans R., Fiers W., Dumont J. E. and Galand P. (1991) Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138: 447-453
78. Polunovsky V. A., Wendt C. H., Ingbar D. H., Peterson M. S. and Bitterman P. B. (1994) Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp. Cell Res. 214: 584-594
79. Jiang K., Zhong B., Gilvary D. L., Corliss B. C., Hong-Geller E., Wei S. et al. (2000) Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419-425
80. Thakker G. D., Hajjar D. P., Muller W. A. and Rosengart T. K. (1999) The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J. Biol. Chem. 274: 10002-10007
81. Vanhaesebroeck B. and Alessi D. R. (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346: 561-576
82. Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S. et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868
83. Hermann C., Assmus B., Urbich C., Zeiher A. M. and Dimmeler S. (2000) Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20: 402-409
84. Testa J. R. and Bellacosa A. (2001) AKT plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. USA 98: 10983-10985
85. Romashkova J. A. and Makarov S. S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 33-34
86. Zech B., Kohl R., von Knethen A. and Brune B. (2003) Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases. Biochem. J. 371: 1055-1064
87. Shiojima I. and Walsh K. (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90: 1243-1250
88. Tran J., Master Z., Yu J. L., Rak J., Dumont D. J. and Kerbel R. S. (2002) A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad. Sci. USA 99: 4349-4354
89. Papapetropoulos A., Fulton D., Mahboubi K., Kalb R. G., O'Connor D. S., Li F. et al. (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275: 9102-9105
90. Fukuda S., Foster R. G., Porter S. B. and Pelus L. M. (2002) The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 100: 2463-2471
91. Gliki G., Wheeler-Jones C. and Zachary I. (2002) Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis. Cell Biol. Int. 26: 751-759
92. Fujio Y. and Walsh K. (1999) Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in ananchorage-dependent manner. J. Biol. Chem. 274: 16349-16354
93. Qi J. H. and Claesson-Welsh L. (2001) VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Exp. Cell Res. 263: 173-82
94. Ma H., Calderon T. M., Fallon J. T. and Berman J. W. (2002) Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 164: 79-87
95. Nakagami H., Morishita R., Yamamoto K., Taniyama Y., Aoki M., Matsumoto K. et al. (2001) Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 37: 581-586
96. Kandel E. S. and Hay N. (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253: 210-229
97. Rikitake Y., Hirata K., Kawashima S., Ozaki M., Takahashi T., Ogawa W. et al. (2002) Involvement of endothelial nitric oxide in sphingosine-1-phosphate- induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 22: 108-114
98. Deregibus M. C., Buttiglieri S., Russo S., Bussolati B. and Camussi G. (2003) CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 278: 18008-18014
99. Melter M., Reinders M. E., Sho M., Pal S., Geehan C., Denton M. D. et al. (2000) Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96: 3801-3808
100. Reinders M. E., Sho M., Robertson S. W., Geehan C. S. and Briscoe D. M. (2003) Proangiogenic function of CD40 ligand-CD40 interactions. J. Immunol. 171: 1534-1541
101. Byzova T. V., Goldman C. K., Pampori N., Thomas K. A., Bett A., Shattil S. J. et al. (2000) A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell. 6: 851-860
102. Attwell S., Roskelley C. and Dedhar S. (2000) The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19: 3811-3815
103. Sonoda Y., Matsumoto Y., Funakoshi M., Yamamoto D., Hanks S. K. and Kasahara T. (2000) Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275: 16309-16315
104. Wu C. and Dedhar S. (2001) Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol. 155: 505-510
105. Huang L., Turck C. W., Rao P. and Peters K. G. (1995) GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 11: 2097-2103
106. Kontos C. D., Stauffer T. P., Yang W. P., York J. D., Huang L., Blanar M. A. et al. (1998) Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18: 4131-4140
107. Koblizek T. I., Runting A. S., Stacker S. A., Wilks A. F., Risau W. and Deutsch U. (1997) Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues. Eur. J. Biochem. 244: 774-779
108. Kwak H. J., So J. N., Lee S. J., Kim I. and Koh G. Y. (1999) Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 448: 249-253
109. Witzenbichler B., Maisonpierre P. C., Jones P., Yancopoulos G. D. and Isner J. M. (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J. Biol. Chem. 273: 18514-18521
110. Fujikawa K., de Aos-Scherpenseel I., Jain S. K., Presman E., Christensen R. A. and Varticovski L. (1999) Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp. Cell Res. 253: 663-672
111. Kim I., Kim H. G., Moon S. O., Chae S. W., So J. N., Koh K. N. et al. (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ. Res. 86: 952-959
112. Harfouche R., Hassessian H. M., Guo Y., Faivre V., Srikant CB., Yancopoulos G. D. et al. (2002) Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc. Res. 64: 135-147
113. Kontos C. D., Cha E. H., York J. D. and Peters K. G. (2002) The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol. Cell. Biol. 22: 1704-1713
114. McCarthy M. J., Burrows R., Bell S. C., Christie G., Bell P. R. and Brindle N. P. (1999) Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1. Lab. Invest. 79: 889-895
115. Yabkowitz R., Meyer S., Black T., Elliott G., Merewether L. A. and Yamane H. K. (1999) Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 93: 1969-1979
116. Yabkowitz R., Meyer S., Yanagihara D., Brankow D., Staley T., Elliott G. et al. (1997) Regulation of tie receptor expression on human endothelial cells by protein kinase C-mediated release of soluble tie. Blood 90: 706-715
117. Marron M. B., Hughes D. P., McCarthy M. J., Beaumont E. R. and Brindle N. P. (2000) Tie-1 receptor tyrosine kinase endodomain interaction with SHP2: potential signalling mechanisms and roles in angiogenesis. Adv. Exp. Med. Biol. 476: 35-46
118. Jones N., Iljin K., Dumont D. J. and Alitalo K. (2001) Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2: 257-267
119. Carmeliet P., Lampugnani M. G., Moons L., Breviario F., Compernolle V., Bono F. et al. (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157
120. Wright T. J., Leach L., Shaw P. E. and Jones P. (2002) Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Exp. Cell Res. 280: 159-168
121. Lin M. T., Yen M. L., Lin C. Y. and Kuo M. L. (2003) Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol. Pharmacol. 64: 1029-1036
122. Corada M., Liao F., Lindgren M., Lampugnani M. G., Breviario F., Frank R. et al. (2001) Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 97: 1679-1684
123. Urbich C., Dernbach E., Reissner A., Vasa M., Zeiher A. M. and Dimmeler S. (2002) Shear stress-induced endothelial cell migration involves integrin signaling via the fibronectin receptor subunits alpha(5) and beta(1). Arterioscler. Thromb. Vasc. Biol. 22: 69-75
124. Carlson T. R., Feng Y., Maisonpierre P. C., Mrksich M. and Morla A. O. (2001) Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276: 26516-26525
125. Camenisch G., Pisabarro M. T., Sherman D., Kowalski J., Nagel M., Hass P. et al. (2002) ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha v beta 3 and induces blood vessel formation in vivo. J. Biol. Chem. 277: 17281-17290
126. Landry J. and Huot J. (1999) Regulation of actin dynamics by stress-activated protein kinase 2 (SAPK2)-dependent phosphorylation of heat-shock protein of 27 kDa (Hsp27). Biochem. Soc. Symp. 64: 79-89
127. Abedi H. and Zachary I. (1997) Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272: 15442-15451
128. Monteiro H. P., Gruia-Gray J., Peranovich T. M., deOliveira L. C. and Stern A. (2000) Nitric oxide stimulates tyrosine phosphorylation of focal adhesion kinase, Src kinase and mitogen-activated protein kinases in murine fibroblasts. Free Radic. Biol. Med. 28: 174-182
129. Dimmeler S., Dernbach E. and Zeiher AM. (2000) Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 477: 258-262
130. Van Wetering S., Van Den Berk N., Van Buul J. D., Mul F. P., Lommerse I., Mous R. et al. (2003) VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am. J. Physiol. Cell Physiol. 285: 343-352
131. Soga N., Connolly J. O., Chellaiah M., Kawamura J. and Hruska K. A. (2001) Rac regulates vascular endothelial growth factor stimulated motility. Cell Commun. Adhes. 8: 1-13
132. Soga N., Namba N., McAllister S., Cornelius L., Teitelbaum S. L., Dowdy S. F. et al. (2001) Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp. Cell Res. 269: 73-87
133. Wojciak-Stothard B. and Ridley A. J. (2003) Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases. J. Cell Biol. 161: 429-439
134. Niu J., Profirovic J., Pan H., Vaiskunaite R. and Voyno-Yasenetskaya T. (2003) G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production. Circ. Res. 93: 848-856
135. Seabra M. C. (1998) Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal. 10: 167-172
136. Kaibuchi K., Kuroda S. and Amano M. (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68: 459-486
137. Uchida S., Watanabe G., Shimada Y., Maeda M., Kawabe A., Mori A. et al. (2000) The suppression of small GTPase rho signal transduction pathway inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 269: 633-640
138. Hippenstiel S., Schmeck B., N'Guessan P. D., Seybold J., Jkrull M., Preissner K. et al. (2002) Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: 830-838
139. Van Nieuw-Amerongen G. P., Koolwijk P., Versteilen A. and van Hinsbergh V. W. (2003) Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler. Thromb. Vasc. Biol. 23: 211-217
140. Park H. J., Kong D., Iruela-Arispe L., Begley U., Tang D. and Galper J. B. (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ. Res. 91: 143-150
141. Vincent L., Soria C., Mirshahi F., Opolon P., Mishal Z., Vannier J. P. et al. (2002) Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models. Arterioscler. Thromb. Vasc. Biol. 22: 623-629
142. Kiosses W. B., Shattil S. J., Pampori N. and Schwartz M. A. (2001) Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat. Cell Biol. 3: 316-320
143. Waschke J., Baumgartner W., Adamson R. H., Zeng M., Aktories K., Barth H. et al. (2004) Requirement of Rac activity for maintenance of capillary endothelial barrier properties. Am. J. Physiol. Heart Circ. Physiol. 286: 394-401
144. Eriksson A., Cao R., Roy J., Tritsaris K., Wahlestedt C., Dissing S. et al. (2003) Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 107: 1532-1538
145. Dormond O., Foletti A., Paroz C. and Ruegg C. (2001) NSAIDs inhibit alphaVbeta3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat. Med. 7: 1041-1047
146. Lampugnani M. G., Zanetti A., Breviario F., Balconi G., Orsenigo F., Corada M. et al. (2002) VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol. Biol. Cell. 13: 1175-1189
147. Bayless K. J. and Davis G. E. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J. Cell Sci. 115: 1123-1136
148. Tzima E., Kiosses W. B., del Pozo M. A., Schwartz M. A. (2003) Localized cdc42 activation, detected using a novel assay, mediates microtubule organizing center positioning in endothelial cells in response to fluid shear stress. J. Biol. Chem. 278: 31020-31023
149. Kouklis P., Konstantoulaki M., Vogel S., Broman M. and Malik A. R. (2004) Cdc42 regulates the restoration of endothelial barrier function. Circ. Res. 94: 159-166
150. Master Z., Jones N., Tran J., Jones J., Kerbel R. S. and Dumont D. J. (2001) Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. EMBO J. 20: 5919-5928
151. Kiosses W. B., Hood J., Yang S., Gerritsen M. E., Cheresh D. A., Alderson N. et al. (2002) A dominant-negative p65 Pak peptide inhibits angiogenesis. Circ. Res. 90: 697-702
152. Slice L. W., Bui L., Mak C. and Walsh J. H. (2000) Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases. Biochem. Biophys. Res. Commun. 276: 406-410
153. Gately S. and Kerbel R. (2003) Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Prog. Exp. Tumor Res. 37: 179-192
154. Dormond O., Bezzi M., Mariotti A. and Ruegg C. (2002) Prostaglandin E2 promotes integrin alpha v beta 3-dependent endothelial cell adhesion, rac-activation and spreading through cAMP/PKA-dependent signaling. J. Biol. Chem. 277: 45838-45846
155. O'Connor K. L. and Mercurio A. M. (2001) Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem. 276: 47895-47900.
156. Sengupta S., Sellers L. A., Cindrova T., Skepper J., Gherardi E., Sasisekharan R. et al. (2003b) Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res. 63: 8351-8359
157. Dixelius J., Cross M. J., Matsumoto T. and Claesson-Welsh L. (2003) Endostatin action and intracellular signaling: beta-catenin as a potential target? Cancer Lett. 196: 1-12
158. Dixelius J., Cross M., Matsumoto T., Sasaki T., Timpl R. and Claesson-Welsh L. (2002) Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res. 62: 1944-1947
159. Wickstrom S. A., Alitalo K. and Keski-Oja J. (2002) Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 62: 5580-5589
160. Eriksson K., Magnusson P., Dixelius J., Claesson-Welsh L. and Cross M. J. (2003) Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett. 536: 19-24.
161. Kim Y. M., Hwang S., Kim Y. M., Pyun B. J., Kim T. Y., Lee S. T. et al. (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277: 27872-27879
162. Van Wetering S., Van-Buul J. D., Quik S., Mul F. P., Anthony E. C., Ten-Klooster J. P. et al. (2002) Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J. Cell Sci. 115: 1837-1846
163. Urbich C., Dernbach E., Aicher A., Zeiher A. M. and Dimmeler S. (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106: 981-986
164. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J. et al. (2002) Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 277: 3101-3108
165. Maulik N. (2002) Redox signaling of angiogenesis. Antioxid. Redox. Signal. 4: 805-815
166. Rosenfeldt H. M., Hobson J. P., Milstien S. and Spiegel S. (2001) The sphingosine-1-phosphate receptor EDG1 is essential for platelet-derived growth factor-induced cell motility. Biochem. Soc. Trans. 29: 836-839
167. English D., Brindley D. N., Spiegel S. and Garcia J. G. (2002) Lipid mediators of angiogenesis and the signalling pathways they initiate. Biochim. Biophys. Acta 1582: 228-239
168. Morales-Ruiz M., Lee M. J., Zollner S., Gratton J. P., Scotland R., Shiojima I. et al. (2001) Sphingosine 1-phosphate activates Akt, nitric oxide production and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J. Biol. Chem. 276: 19672-19677
169. Lee M. J., Thangada S., Paik J. H., Sapkota G. P., Ancellin N., Chae S. S. et al. (2001) Akt-mediated phosphorylation of the G protein-coupled receptor EDG1 is required for endothelial cell chemotaxis. Mol. Cell. 8: 693-704
170. Hobson J. P., Rosenfeldt H. M., Barak L. S., Olivera A., Poulton S., Caron M. G. et al. (2001) Role of the sphingosine-1-phosphate receptor EDG1 in PDGF-induced cell motility. Science 291: 1800-1803
171. Liu Y., Wada R., Yamashita T., Mi Y., Deng C. X., Hobson J. P. et al. (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106: 951-961
172. Cascone I., Audero E., Giraudo E., Napione L., Maniero F., Philips M. R. et al. (2003) Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. Blood 102: 2482-2490
173. Davis S., Gale N. W., Aldrich T. H., Maisonpierre P. C., Lhotak V., Pawson T. et al. (1994) Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266: 816-819
174. Flanagan J. G. and Vanderhaeghen P. (1998) The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21: 309-345
175. Maekawa H., Oike Y., Kanda S., Ito Y., Yamada Y., Kurihara H. et al. (2003) Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature. Arterioscler. Thromb. Vasc. Biol. 23: 2008-2014
176. Huynh-Do U., Vindis C., Liu H., Cerretti D. P., McGrew J. T., Enriquez M. et al. (2002) Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J. Cell Sci. 115: 3073-3081
177. Steinle J. J., Meininger C. J., Forough R., Wu G., Wu M. H. and Granger H. J. (2002) Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 277: 43830-43835
178. Chen Z. Q., Fisher R. J., Riggs C. W., Rhim J. S. and Lautenberger J. A. (1997) Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res. 57: 2013-2019
179. Sato Y., Abe M., Tanaka K., Iwasaka C., Oda N., Kanno S. et al. (2000) Signal transduction and transcriptional regulation of angiogenesis. Adv. Exp. Med. Biol. 476: 109-115
180. Wang H. and Keiser J. A. (2000) Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem. Biophys. Res. Commun. 272: 900-905
181. Oikawa T. and Yamada T. (2003) Molecular biology of the Ets family of transcription factors. Gene 303: 11-34
182. Besser D., Bardelli A., Didichenko S., Thelen M., Comoglio P. M., Ponzetto C. et al. (1997) Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Oncogene 14: 705-711
183. Genersch E., Hayess K., Neuenfeld Y. and Haller H. (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 113: 4319-4330
184. Uyeno L. A., Newman-Keagle J. A., Cheung I., Hunt T. K., Young D. M. and Boudreau N (2001) Hox D3 expression in normal and impaired wound healing. J. Surg. Res. 100: 46-56
185. Boudreau N., Andrews C., Srebrow A., Ravanpay A. and Cheresh D. A. (1997) Induction of the angiogenic phenotype by Hox D3. J. Cell Biol. 139: 257-264
186. Dumler I., Kopmann A., Weis A., Mayboroda O. A., Wagner K., Gulba D.C. et al. (1999) Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19: 290-297
187. Thorne R. F., Legg J. W. and Isacke C. M. (2004) The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J. Cell Sci. 117: 373-380.
188. Bhagwat S. V., Petrovic N., Okamoto Y. and Shapiro L. H. (2003) The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. Blood 101: 1818-1826
189. Connolly J. O., Soga N., Guo X. L., Alvarez U. and Hruska K. A. (2000) Rac is essential in the transformation of endothelial cells by polyoma middle T. Cell Adhes. Commun. 7: 409-422
190. Hla T. and Maciag T. (1990) An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265: 9308-9313
191. Lee M. J., Van-Brocklyn J. R., Thangada S., Liu C. H., Hand A. R., Menzeleev R. et al. (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG1. Science 279: 1552-1555
192. Lee M. J., Evans M. and Hla T. (1996) The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J. Biol. Chem. 271: 11272-11279
193. Paik J. H., Chae S. S., Lee M. J., Thangada S. and Hla T. (2001) Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J. Biol. Chem. 276: 11830-11837
194. Gerety S. S., Wang H. U., Chen Z. F. and Anderson D. J. (1999) Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4: 403-414
195. Pandey A., Shao H., Marks R. M., Polverini P. J. and Dixit V. M. (1995) Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268: 567-569
196. Cheng N. and Chen J. (2001) Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism. J. Biol. Chem. 276: 13771-13777
197. Cheng N., Brantley D. M., Liu H., Lin Q., Enriquez M., Gale N. et al. (2002) Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Mol. Cancer Res. 1: 2-11
198. Brantley D. M., Cheng N., Thompson E. J., Lin Q., Brekken R. A., Thorpe et al. (2002) Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21: 7011-7026
199. Miao H., Wei B. R., Peehl D. M., Li Q., Alexandrou T., Schelling J. R. et al. (2001) Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell Biol. 3: 527-30
200. Wang B., Xiao Y., Ding B. B., Zhang N., Yuan X., Gui L. et al. (2003) Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 4: 19-29
201. Huminiecki L., Gorn M., Suchting S., Poulsom R. and Bicknell R. (2002) Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 79: 547-552
202. Kanda S., Miyata Y. and Kanetake H. (2004) Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1. Possible involvement of c-Akt. J. Biol. Chem. 279: 4007-4016
203. Tsuda S., Ohtsuru A., Yamashita S., Kanetake H. and Kanda S. (2002) Role of c-Fyn in FGF2-mediated tube-like structure formation by murine brain capillary endothelial cells. Biochem. Biophys. Res. Commun. 290: 1354-1360
204. Zimrin A. B., Pepper M. S., McMahon G. A., Nguyen F., Montesano R. and Maciag T. (1996) An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J. Biol. Chem. 271: 32499-32502
205. Liu Z. J., Shirakawa T., Li Y., Soma A., Oka M., Dotto G. P. et al. (2003) Regulation of Notch1 and D114 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol. Cell Biol. 23: 14-25
206. Uyttendaele H., Marazzi G., Wu G., Yan Q., Sassoon D. and Kitajewski J. (1996) Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122: 2251-2259
207. Uyttendaele H., Soriano J. V., Montesano R. and Kitajewski J. (1998) Notch-4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev. Biol. 196: 204-217
208. Leong K. G., Hu X., Li L., Noseda M., Larrivee B., Hull C. et al. (2002) Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol. Cell. Biol. 22: 2830-2841
209. Uyttendaele H., Ho J., Rossant J. and Kitajewski J. (2001) Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. USA 98: 5643-5648
210. Kanda S., Mochizuki Y., Suematsu T., Miyata Y., Nomata K. and Kanetake H. (2003) Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J. Biol. Chem. 278: 8244-8249.
211. Pola R., Ling L. E., Silver M., Corbley M. J., Kearney M., Blake Pepinsky R et al. (2001) The morphogen Sonic hedge-hog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat. Med. 7: 706-711
212. Myers C., Charboneau A. and Boudreau N. (2000) Homeobox B3 promotes capillary morphogenesis and angiogenesis. J. Cell Biol. 148: 343-351
213. Myers C., Charboneau A., Cheung I., Hanks D. and Boudreau N. (2002) Sustained expression of homeobox D10 inhibits angiogenesis. Am. J. Pathol. 161: 2099-2109
214. Belotti D., Clausse N., Flagiello D., Alami Y., Daukandt M., Deroanne C. et al. (1998) Expression and modulation of homeobox genes from cluster B in endothelial cells. Lab. Invest. 78: 1291-1299
215. Goodwin A. M. and D'Amore P. A. (2002) Wnt signaling in the vasculature. Angiogenesis 5: 1-9
216. Dufourcq P., Couffinhal T., Ezan J., Barandon L., Moreau C., Daret D. et al. (2002) FrzA, a secreted frizzled related protein, induced angiogenic response. Circulation 106: 3097-3103
217. Robitaille J., MacDonald M. L., Kaykas A., Sheldahl L. C., Zeisler J., Dube M. P. et al. (2002) Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 32: 326-330
218. Ishikawa T., Tamai Y., Zorn A. M., Yoshida H., Seldin M. F., Nishikawa S. et al. (2001) Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 128: 25-33
219. Monkley S. J., Delaney S. J., Pennisi D. J., Christiansen J. H. and Wainwright B. J. (1996) Targeted disruption of the Wnt2 gene results in placentation defects. Development 122: 3343-3353
220. Hanai J., Gloy J., Karumanchi S. A., Kale S., Tang J., Hu G. et al. (2002) Endostatin is a potential inhibitor of Wnt signaling. J. Cell Biol. 158: 529-539
221. Derynck R. and Zhang Y. E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584
222. Duff S. E., Li C., Garland J. M. and Kumar S. (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 17: 984-992
223. Yu Q. and Stamenkovic I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163-176
224. Miyazono K., ten Dijke P. and Heldin C. H. (2000) TGF-beta signaling by Smad proteins. Adv. Immunol. 75: 115-157
225. Azuma H. (2000) Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J. Med. Invest. 47: 81-90
226. Goumans M. J., Lebrin F. and Valdimarsdottir G. (2003) Controlling the angiogenic switch: a balance between two distinct TGF-β receptor signaling pathways. Trends Cardiovasc. Med. 13: 301-307
227. Vinals F. and Pouyssegur J. (2001) Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol. Cell. Biol. 21: 7218-7230
228. Larsson J., Goumans M. J., Sjostrand L. J., van Rooijen M. A., Ward D., Leveen P. et al. (2001) Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20: 1663-1673
229. Oh S. P., Seki T., Goss K. A., Imamura T., Yi Y., Donahoe P. K. et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 97: 2626-2631
230. Bagnato A. and Spinella F. (2003) Emerging role of endothelin-1 in tumor angiogenesis. Trends Endocrinol. Metab. 14: 44-50
231. Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., DiPietro L. A., Elner V. M. et al. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801
232. Feil C. and Augustin H. G. (1998) Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem. Biophys. Res. Commun. 247: 38-45
233. Gupta S. K., Lysko P. G., Pillarisetti K., Ohlstein E. and Stadel J. M. (1998) Chemokine receptors in human endothelial cells functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 273: 4282-4287
234. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y. et al. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638
235. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y. et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591-594
236. Ganju R. K., Brubaker S. A., Meyer J., Dutt P., Yang Y., Qin S. et al. (1998) The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 273: 23169-23175
237. Klein S., de Fougerolles A. R., Blaikie P., Khan L., Pepe A., Green C.D. et al. (2002) Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation. Mol. Cell Biol. 22: 5912-5922
238. Scatena M., Almeida M., Chaisson M. L., Fausto N., Nicosia R.F. and Giachelli C.M. (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J. Cell Biol. 141: 1083-1093
239. Zhu Y., Sun Y., Xie L., Jin K., Sheibani N. and Greenberg D. A. (2003) Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke 34: 2483-2488
240. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S. and Comoglio P. M. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3: 347-361
241. Kroon M. E., Koolwijk P., van der Vecht B. and Van Hinsbergh V. W. (2001) Hypoxia in combination with FGF2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J. Cell Sci. 114: 825-833
242. Lelkes P. I. and Waters C. R. (2000) Reactive oxygen species and angiogenesis. In: Angiogenesis in Health and Disease, pp. 199-214, Rubany G. M. (ed.), Marcel Dekker, New York
243. Yasuda M., Ohzeki Y., Shimizu S., Naito S., Ohtsuru A., Yamamoto T. et al. (1999) Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 64: 249-258
244. Stoica, G. E., Kuo, A., Powers C., Bowden E. T., Sale E. B., Riegel A. T. et al. (2002) Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J. Biol. Chem. 277: 35990-35998
245. Stoica, G. E., Kuo A., Aigner A., Sunitha I., Souttou B. Malerczyk C. et al. (2001) Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J. Biol. Chem. 276: 16772-16779
246. Deuel T. F., Zhang N., Yeh H. J., Silos-Santiago I. and Wang Z. Y. (2002) Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch. Biochem. Biophys. 397: 162-171
247. Kim Y. M., Kim Y. M., Lee Y. M., Kim H. S., Kim J. D. Choi Y. et al. (2002) TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J. Biol. Chem. 277: 6799-6805
248. Versteeg H. H., Peppelenbosch M. P. and Spek C. A. (2003) Tissue factor signal transduction in angiogenesis. Carcinogenesis 24: 1009-1013
249. Hyder S. M., Stancel G. M., Chiappetta C., Murthy L., BoettgerTong H. L. and Makela S. (1996) Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res. 56: 3954-3960
250. Ravindranath N., Little-Ihrig L., Phillips H. S., Ferrara N. and Zeleznik A. J. (1992) Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131: 254-260
251. Gura T. (1995) Estrogen: key player in heart disease among women. Science 269: 771-773
252. Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhartiya D., Cid M. C. et al. (1995) Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763
253. Soncin F., Fafeur V. and Vandenbunder B. (1999) Transcription factors and angiogenesis. Pathol. Biol. (Paris) 47: 358-363
254. Pérez Pomares J. M. and Muñoz-Chápuli R. (2002) Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans. Anat. Rec. 268: 343-351